The World Health Organization has declared a new Ebola outbreak in the Democratic Republic of Congo a public health emergency of international concern. This is the most serious designation short of a pandemic emergency, which was how COVID-19 was classified.
The announcement came just days after health officials confirmed a deadly, fast-moving strain of Ebola was spreading across one of the world’s most remote and conflict-torn regions. It had already crossed an international border.
The current outbreak, centered in Congo’s northeastern Ituri province, has been confirmed as the Bundibugyo strain: a rare and understudied Ebola virus for which no approved vaccine or treatment exists.
As of this writing, at least 88 people have died and more than 336 suspected cases have been recorded across the health zones of Rwampara and Mongwalu, with additional cases confirmed in Bunia, Ituri’s provincial capital. More alarming still, the virus has already reached Uganda.
A 59-year-old Congolese man died of confirmed Bundibugyo Ebola in Kampala on May 14 as the first confirmed international spread of this outbreak. Then, on May 16, a second laboratory-confirmed case with no apparent link to the first was reported in Kampala. It was an individual who had traveled from DRC. This raises the alarming possibility that the exposure chain within Uganda is larger than currently known.
This is Congo’s 17th Ebola outbreak since the virus was first identified there in 1976. Each one has tested the limits of the global health response. This one may prove difficult to control.
Why This Ebola Outbreak Is More Concerning
Past Congo outbreaks including the catastrophic 2018 to 2020 epidemic that killed nearly 2,300 people were caused by the Zaire strain of Ebola. A vaccine called rVSV-ZEBOV (Ervebo) was developed against the Zaire strain following the catastrophic 2014 to 2016 Ebola outbreak.
The 2018 to 2020 Ebola pandemic used a process called ring vaccination where contacts of confirmed cases were rapidly immunized. This process helped suppress spread, even in an active conflict zone.
The problem is that there is no proven vaccine against the Bundibugyo Ebola strain. The Bundibugyo strain of Ebola causes sudden flu-like symptoms with fever that quickly progress to severe vomiting, diarrhea, and in many cases, bleeding. Ebola is also called Ebola hemorrhagic fever because of the bleeding. The mortality rate for the Bundibugyo strain is estimated to be between 30% and 50%
The Bundibugyo strain was first identified in 2007 in Uganda’s Bundibugyo district and caused an outbreak in Congo in 2012. Experimental vaccines have been tested in animal models, but none have completed the clinical trial pathway to approval.
In a fast-moving outbreak with cases already appearing in a major capital city, that gap is the central challenge facing public health officials now.
A further complication: standard rapid diagnostic field tests often miss the Bundibugyo strain. Unlike Zaire, which has well-validated point-of-care tests, Bundibugyo is rare enough that field diagnostics were not designed for it. This means that the confirmed case counts almost certainly understate true disease burden compounding the already-delayed detection timeline.
The Kampala cases also illustrate how quickly cross-border transmission can escape notice. The first Kampala patient traveled to Uganda via public transportation, died in a hospital and his body was then transported back across the border to DRC for burial. Each step was a potential exposure event.
Africa CDC Director Jean Kaseya acknowledged uncertainty about what protective gear healthcare workers had used when treating the patient, noting plainly: “We don’t have manufacturing for PPE.” That admission captures the asymmetry at the heart of this outbreak: the virus moves faster than the infrastructure designed to stop it.
Another factor that makes this outbreak especially concerning is how long it appears to have been spreading before it was identified. The suspected index case was a nurse who died at the Evangelical Medical Centre in Bunia after presenting with classic symptoms.
By the time that case triggered an official response, contact tracers were already facing a weeks-long chain of potential exposures they could not fully reconstruct. This made is significantly harder to find contacts for all the cases.
Detection was further complicated by Ituri’s geography and security situation. The province sits more than 1,000 kilometers from Kinshasa, connected by poor roads and crossed by active armed conflict. These conditions slow everything from specimen transport to response team deployment. Médecins Sans Frontières has teams in the area and is mobilizing additional resources, but the operational environment remains extraordinarily difficult.
Some experts have also raised the question whether cuts to global health funding have compromised the early warning infrastructure that might have caught this sooner.
Epidemiologist Jennifer Nuzzo speculated publicly that the delayed detection could reflect the erosion of programs designed to identify exactly these kinds of outbreaks before they reach hundreds of cases.
The historical rarity of Bundibugyo is also itself part of the problem. Dr. Jean-Jacques Muyembe — the Congolese virologist who co-discovered Ebola in 1976 — has noted that all but one of Congo’s previous outbreaks involved the Zaire strain.
The global health community’s deep investment in Zaire countermeasures was rational and life-saving, but it left Bundibugyo comparatively understudied, underdiagnosed, and without a licensed vaccine or therapeutic to deploy when it emerged again.
What the WHO Declaration Means
A public health emergency of international concern, or PHEIC, is the WHO’s highest alert designation outside of a formal pandemic emergency. It triggers coordinated international response mechanisms, unlocks emergency funding, and obligates member nations to heightened surveillance and reporting.
WHO Director-General Tedros Adhanom Ghebreyesus was explicit that this is not a pandemic emergency requiring border closures. WHO advised all nations against restricting trade or travel, noting that such measures are not grounded in science. Such measures tend to push movement toward unmonitored informal crossings, and risk undermining both response logistics and local economies.
But a PHEIC is a signal that the situation has crossed a threshold. The combination of a strain with no approved countermeasures, confirmed spread into a second country, cases in a major urban center and a delayed detection timeline can no longer be treated as a regional concern.
What Comes Next To Contain The Spread Of Ebola
The immediate priorities are containment, contact tracing, and supportive care for confirmed cases. International partners including the WHO, Africa CDC and Médecins Sans Frontières are scaling up on the ground. WHO released $500,000 from its Contingency Fund for Emergencies to support surveillance, contact tracing, laboratory testing and clinical care. This is a meaningful first step, though a modest sum relative to what a multi-country Ebola response in a conflict zone demands.
Experimental vaccine candidates for Bundibugyo exist, and emergency use authorization pathways could potentially accelerate their deployment. Yet, regulatory processes take time, and time is precisely what an Ebola outbreak in a conflict zone with a compromised detection baseline does not have.
For the global health community, this outbreak also arrives at a fraught moment with international health funding is under pressure. The surveillance networks and rapid-response infrastructure built painstakingly after the 2014 West Africa epidemic which killed more than 11,000 people and exposed catastrophic gaps in global preparedness are thinner than before.
There are many reasons to be concerned about this particular Ebola outbreak. The question now is whether the global response: its funding, its speed and its political will, ultimately will be enough to contain the spread.
